Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age

Clinical Science

Volumn 129, Issue 11, 2015, Pages 963-972

  Martino, Francesco ^a   Carlomosti, Fabrizio ^b   Avitabile, Daniele ^c   Persico, Luca ^d   Picozza, Mario ^b   Barillà, Francesco ^a   Arca, Marcello ^a   Montali, Anna ^a   Martino, Eliana ^a   Zanoni, Cristina ^a   Parrotto, Sandro ^a   Magenta, Alessandra ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Cardiovascular disease; Hypercholesterolaemia; Lipoproteins; MiR 33; MiRNAs; Paediatrics

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 33A; MICRORNA 33B; UNCLASSIFIED DRUG; APOB PROTEIN, HUMAN; APOLIPOPROTEIN B100; GENETIC MARKER; GLUCOSE BLOOD LEVEL; MIRN33 MICRORNA, HUMAN;

ADOLESCENT; ARTICLE; BODY MASS; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; CASE CONTROL STUDY; CHILD; GENETIC MARKER; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; ONSET AGE; PREDICTIVE VALUE; REGRESSION ANALYSIS;

ADOLESCENT; AGE OF ONSET; APOLIPOPROTEIN B-100; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENETIC MARKERS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LEAST-SQUARES ANALYSIS; MALE; MICRORNAS; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84952011386     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150235     Document Type: Article

References (37)

1. Fernández, C., Lobo, M., del, V.T., Gómez-Coronado, D. and Lasunción, M.A. (2004) Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp. Cell Res. 300, 109-120
2. Ikonen, E. (2006) Mechanisms for cellular cholesterol transport: defects and human disease. Physiol. Rev. 86, 1237-1261
3. Upadhyay, R.K. (2015) Emerging risk biomarkers in cardiovascular diseases and disorders. J. Lipids 2015, 971453
4. Kusters, D.M., Vissers, M.N., Wiegman, A., Kastelein, J.J.P. and Hutten, B.A. (2010) Treatment of dyslipidaemia in childhood. Expert Opin. Pharmacother. 11, 739-753
5. Palinski, W. and Napoli, C. (2002) The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 16, 1348-1360
6. Martino, F., Loffredo, L., Carnevale, R., Sanguigni, V., Martino, E., Catasca, E., Zanoni, C., Pignatelli, P. and Violi, F. (2008) Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 122, e648-e655
7. McNeal, C.J., Dajani, T., Wilson, D., Cassidy-Bushrow, A.E., Dickerson, J.B. and Ory, M. (2010) Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease. Curr. Atheroscler. Rep. 12, 20-28
8. McGill, Jr, H.C., McMahan, C.A., Herderick, E.E., Malcom, G.T., Tracy, R.E. and Jack, P. (2000) Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 72 (Suppl.), 1307S-1315S
9. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
10. Winter, J., Jung, S., Keller, S., Gregory, R.I. and Diederichs, S. (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234
11. Olson, E.N. (2014) MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med. 6, 239ps3
12. Fasanaro, P., D'Alessandra, Y., Magenta, A., Pompilio, G. and Capogrossi, M.C. (2015) MicroRNAs: promising biomarkers and therapeutic targets of acute myocardial ischemia. Curr. Vasc. Pharmacol. 13, 305-315
13. Magenta, A., Greco, S., Gaetano, C. and Martelli, F. (2013) Oxidative stress and microRNAs in vascular diseases. Int. J. Mol. Sci. 14, 17319-17346
14. Zhu, H. and Fan, G.-C. (2011) Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am. J. Cardiovasc. Dis. 1, 138-149
15. Creemers, E.E., Tijsen, A.J. and Pinto, Y.M. (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495
16. Condorelli, G., Latronico, M.V.G. and Dorn, G.W. (2010) MicroRNAs in heart disease: Putative novel therapeutic targets? Eur. Heart J. 31, 649-658
17. Najafi-Shoushtari, S.H., Kristo, F., Li, Y., Shioda, T., Cohen, D.E., Gerszten, R.E. and Näär, A.M. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569
18. Shao, W. and Espenshade, P.J. (2012) Expanding roles for SREBP in metabolism. Cell Metab. 16, 414-419
19. Fernández-Hernando, C. and Moore, K.J. (2011) MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 31, 2378-2382
20. Rayner, K.J., Sheedy, F.J., Esau, C.C., Hussain, F.N., Temel, R.E., Parathath, S., van Gils, J.M., Rayner, A.J., Chang, A.N., Suarez, Y. et al. (2011) Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921-2931
21. Rayner, K.J., Esau, C.C., Hussain, F.N., McDaniel, A.L., Marshall, S.M., van Gils, J.M., Ray, T.D., Sheedy, F.J., Goedeke, L., Liu, X. et al. (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407
22. Karunakaran, D., Thrush, A.B., Nguyen, M.-A., Richards, L., Geoffrion, M., Singaravelu, R., Ramphos, E., Shangari, P., Ouimet, M., Pezacki, J.P. et al. (2015) Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis. Circ. Res. 117, 266-278
23. Campagna, F., Martino, F., Bifolco, M., Montali, A., Martino, E., Morrone, F., Antonini, R., Cantafora, A., Verna, R. and Arca, M. (2008) Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis 196, 356-364
24. Tanner, J.M. (1981) Growth and maturation during adolescence. Nutr. Rev. 39, 43-55
25. Robciuc, M.R., Maranghi, M., Lahikainen, A., Rader, D., Bensadoun, A., Öörni, K., Metso, J., Minicocci, I., Ciociola, E., Ceci, F. et al. (2013) Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler. Thromb. Vasc. Biol. 33, 1706-1713
26. National Heart, Lung, and Blood Institute (1980) The Lipid Research Clinics Population Studies Data Book, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda
27. Zampetaki, A., Willeit, P., Drozdov, I., Kiechl, S. and Mayr, M. (2012) Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc. Res. 93, 555-562
28. Kroh, E.M., Parkin, R.K., Mitchell, P.S. and Tewari, M. (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301
29. -ΔΔCT method. Methods 25, 402-408
30. Bengoechea-Alonso, M.T. and Ericsson, J. (2007) SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell Biol. 19, 215-222
31. Soufi, M., Ruppert, V., Kurt, B. and Schaefer, J.R. (2012) The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH). Gene 499, 218-222
32. Simionescu, N., Niculescu, L.S., Sanda, G.M., Margina, D. and Sima, A.V. (2014) Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera. Mol. Biol. Rep. 41, 5765-5773
33. Narverud, I., Ueland, T., Nenseter, M.S., Retterstøl, K., Telle-Hansen, V.H., Halvorsen, B., Ose, L., Aukrust, P. and Holven, K.B. (2011) Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor a system and interleukin-10. Atherosclerosis 214, 163-168
34. Im, S.-S., Yousef, L., Blaschitz, C., Liu, J.Z., Edwards, R.A., Young, S.G., Raffatellu, M. and Osborne, T.F. (2011) Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13, 540-549
35. Chen, Z., Wen, L., Martin, M., Hsu, C.Y., Fang, L., Lin, F.M., Lin, T.Y., Geary, M.J., Geary, G.G., Zhao, Y. et al. (2015) Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation 131, 805-814
36. Khera, A.V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M.F., Jafri, K., French, B.C., Phillips, J.A., Mucksavage, M.L., Wilensky, R.L. et al. (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364, 127-135
37. Omran, A., Elimam, D., He, F., Peng, J. and Yin, F. (2012) Potential role of blood microRNAs as non-invasive biomarkers for early detection of asymptomatic coronary atherosclerosis in obese children with metabolic syndrome. Med. Hypotheses 79, 889-893